Your browser doesn't support javascript.
loading
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.
Senapati, Jayastu; Dhawan, Rishi; Aggarwal, Mukul; Kumar, Pradeep; Kumar Vishwanathan, Ganesh; Dass, Jasmita; Tyagi, Seema; Mahapatra, Manoranjan; Seth, Tulika.
Afiliação
  • Senapati J; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Dhawan R; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Aggarwal M; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Kumar P; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Kumar Vishwanathan G; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Dass J; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Tyagi S; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Mahapatra M; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
  • Seth T; Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
Leuk Lymphoma ; 62(6): 1514-1517, 2021 06.
Article em En | MEDLINE | ID: mdl-33448885
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2021 Tipo de documento: Article